HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yu D Vinnichuk Selected Research

Neoplasms (Cancer)

12/2009Expression of E-cadherin in drug resistant human breast cancer cells and their sensitivity to lymphokine-activated lymphocytes action.
12/2008Expression of CD40 by the cells of benign and malignant breast tumors and antitumor action of autologous lymphocytes against chemoresistant and chemosensitive tumors.
3/2008The use of doxorubicine at low doses for elevation of LAK-activity toward explants and cells of MC-rhabdomyosarcoma and B16 melanoma resistant to doxorubicin.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yu D Vinnichuk Research Topics

Disease

3Neoplasms (Cancer)
12/2009 - 03/2008
2Breast Neoplasms (Breast Cancer)
12/2009 - 12/2008
1Rhabdomyosarcoma
03/2008
1Experimental Melanoma
03/2008

Drug/Important Bio-Agent (IBA)

2ParaffinIBA
12/2009 - 12/2008
2Pharmaceutical PreparationsIBA
12/2009 - 12/2008
1soybean lectin receptorIBA
12/2009
1Proteins (Proteins, Gene)FDA Link
12/2009
1Cadherins (E-Cadherin)IBA
12/2009
1Nuclear Antigens (Extractable Nuclear Antigens)IBA
12/2009
1Doxorubicin (Adriamycin)FDA LinkGeneric
03/2008
1Interleukin-2 (IL2)IBA
03/2008
1Hematoxylin (Haematoxylon)IBA
03/2008